- Home
- AACG vs XAIR Comparison
AACG vs XAIR Comparison
Compare AACG & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- XAIR
- Stock Information
- Founded
- AACG 1999
- XAIR 2011
- Country
- AACG China
- XAIR United States
- Employees
- AACG N/A
- XAIR N/A
- Industry
- AACG Other Consumer Services
- XAIR Medical/Dental Instruments
- Sector
- AACG Real Estate
- XAIR Health Care
- Exchange
- AACG Nasdaq
- XAIR Nasdaq
- Market Cap
- AACG 31.9M
- XAIR 33.6M
- IPO Year
- AACG N/A
- XAIR N/A
- Fundamental
- Price
- AACG $0.84
- XAIR $0.40
- Analyst Decision
- AACG
- XAIR Strong Buy
- Analyst Count
- AACG 0
- XAIR 4
- Target Price
- AACG N/A
- XAIR $3.67
- AVG Volume (30 Days)
- AACG 24.5K
- XAIR 782.5K
- Earning Date
- AACG 11-07-2024
- XAIR 02-10-2025
- Dividend Yield
- AACG N/A
- XAIR N/A
- EPS Growth
- AACG N/A
- XAIR N/A
- EPS
- AACG N/A
- XAIR N/A
- Revenue
- AACG $35,747,843.00
- XAIR $2,342,000.00
- Revenue This Year
- AACG N/A
- XAIR $230.80
- Revenue Next Year
- AACG N/A
- XAIR $265.55
- P/E Ratio
- AACG N/A
- XAIR N/A
- Revenue Growth
- AACG 15.80
- XAIR 685.91
- 52 Week Low
- AACG $0.50
- XAIR $0.30
- 52 Week High
- AACG $1.65
- XAIR $2.36
- Technical
- Relative Strength Index (RSI)
- AACG 36.73
- XAIR 37.26
- Support Level
- AACG $0.70
- XAIR $0.40
- Resistance Level
- AACG $0.92
- XAIR $0.49
- Average True Range (ATR)
- AACG 0.06
- XAIR 0.04
- MACD
- AACG -0.01
- XAIR -0.01
- Stochastic Oscillator
- AACG 48.28
- XAIR 1.94
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.